Pfizer Expects FDA to Approve Covid Shots for Kids

The video discusses the current status of booster shots in the U.S., focusing on the concept of mixing and matching different vaccines. It highlights the data presented to the FDA, particularly from NIH studies, and the potential approval of these combinations. Additionally, the video covers the anticipated approval of COVID-19 vaccines for children aged 5 to 11, detailing the expected timeline and formulation differences from adult vaccines.

How does the formulation for children differ from that for adults?

What preparations have been made to provide the new formulation for children if approved?